These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 35107865)

  • 1. Risk of hepato-pancreato-biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: A population-based cohort study.
    Yu J; Refsum E; Helsingen LM; Folseraas T; Ploner A; Wieszczy P; Barua I; Jodal HC; Melum E; Løberg M; Blom J; Bretthauer M; Adami HO; Kalager M; Ye W
    United European Gastroenterol J; 2022 Mar; 10(2):212-224. PubMed ID: 35107865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal cancer and cholangiocarcinoma in patients with primary sclerosing cholangitis and inflammatory bowel disease.
    Manninen P; Karvonen AL; Laukkarinen J; Aitola P; Huhtala H; Collin P
    Scand J Gastroenterol; 2015 Apr; 50(4):423-8. PubMed ID: 25636976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies.
    Fung BM; Lindor KD; Tabibian JH
    World J Gastroenterol; 2019 Feb; 25(6):659-671. PubMed ID: 30783370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study.
    Guerra I; Bujanda L; Castro J; Merino O; Tosca J; Camps B; Gutiérrez A; Gordillo Ábalos J; de Castro L; Iborra M; Carbajo AY; Taxonera C; Rodríguez-Lago I; Mesonero F; de Francisco R; Gómez-Gómez GJ; Chaparro M; Tardillo CA; Rivero M; Algaba A; Martín Arranz E; Cañete F; Vicente R; Sicilia B; Antolín B; Prieto V; Márquez L; Benítez JM; Camo P; Piqueras M; Gargallo CJ; Hinojosa E; Huguet JM; Pérez Calle JL; Van Domselaar M; Rodriguez C; Calvet X; Muñoz-Villafranca C; García-Sepulcre MF; Munoz-Garrido P; Fernández-Clotet A; Gómez Irwin L; Hernández S; Guardiola J; Sempere L; González Muñoza C; Hernández V; Beltrán B; Barrio J; Alba C; Moraleja I; López-Sanromán A; Riestra S; Martínez Montiel P; Garre A; Arranz L; García MJ; Martín Arranz MD; Corsino P; Arias L; Fernández-Salazar L; Fernández-Pordomingo A; Andreu M; Iglesias E; Ber Y; Mena R; Arroyo Villarino MT; Mora M; Ruiz L; López-Serrano P; Blazquez I; Villoria A; Fernández M; Bermejo F; Banales JM; Domènech E; Gisbert JP;
    J Crohns Colitis; 2019 Dec; 13(12):1492-1500. PubMed ID: 31063540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality and extraintestinal cancers in patients with primary sclerosing cholangitis and inflammatory bowel disease.
    Ananthakrishnan AN; Cagan A; Gainer VS; Cheng SC; Cai T; Szolovits P; Shaw SY; Churchill S; Karlson EW; Murphy SN; Kohane I; Liao KP
    J Crohns Colitis; 2014 Sep; 8(9):956-63. PubMed ID: 24559536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Primary Sclerosing Cholangitis on Risks of Cancer and Death in People With Inflammatory Bowel Disease, Based on Sex, Race, and Age.
    Trivedi PJ; Crothers H; Mytton J; Bosch S; Iqbal T; Ferguson J; Hirschfield GM
    Gastroenterology; 2020 Sep; 159(3):915-928. PubMed ID: 32445859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer risk, screening and surveillance in primary sclerosing cholangitis.
    Chascsa DM; Lindor KD
    Minerva Gastroenterol Dietol; 2019 Sep; 65(3):214-228. PubMed ID: 31220911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory bowel disease increases the risk of hepatobiliary pancreatic cancer: A two-sample Mendelian randomization analysis of European and East Asian populations.
    Huang J; Li X; Hong J; Huang L; Jiang Q; Guo S; Rong Y; Guo G
    Cancer Med; 2023 Jun; 12(12):13599-13609. PubMed ID: 37184160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary sclerosing cholangitis associated with inflammatory bowel disease: an observational study in a Southern Europe population focusing on new therapeutic options.
    Franceschet I; Cazzagon N; Del Ross T; D'Incà R; Buja A; Floreani A
    Eur J Gastroenterol Hepatol; 2016 May; 28(5):508-13. PubMed ID: 26872110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for malignancy in primary sclerosing cholangitis (PSC).
    Khaderi SA; Sussman NL
    Curr Gastroenterol Rep; 2015 Apr; 17(4):17. PubMed ID: 25786901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer surveillance in patients with primary sclerosing cholangitis.
    Razumilava N; Gores GJ; Lindor KD
    Hepatology; 2011 Nov; 54(5):1842-52. PubMed ID: 21793028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Primary sclerosing cholangitis].
    Boonstra K; Ponsioen CI; Rauws EA; Beuers U
    Ned Tijdschr Geneeskd; 2010; 154():A1476. PubMed ID: 20619015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
    Goss JA; Shackleton CR; Farmer DG; Arnaout WS; Seu P; Markowitz JS; Martin P; Stribling RJ; Goldstein LI; Busuttil RW
    Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary sclerosing cholangitis and cholangiocarcinoma: pathogenesis and modes of diagnostics.
    Ehlken H; Schramm C
    Dig Dis; 2013; 31(1):118-25. PubMed ID: 23797133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study.
    Bergquist A; Glaumann H; Persson B; Broomé U
    Hepatology; 1998 Feb; 27(2):311-6. PubMed ID: 9462625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality and cancer risk related to primary sclerosing cholangitis in a Swedish population-based cohort.
    de Valle MB; Björnsson E; Lindkvist B
    Liver Int; 2012 Mar; 32(3):441-8. PubMed ID: 22098097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Excerpt from the 2022 American Association for the Study of Liver Diseases clinical practice guideline: management of primary sclerosing cholangitis and cholangiocarcinoma].
    Yuan J; Han GH
    Zhonghua Gan Zang Bing Za Zhi; 2023 Jan; 31(1):35-41. PubMed ID: 36948847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignancies in Primary Sclerosing Cholangitis--A Continuing Threat.
    Bonato G; Cristoferi L; Strazzabosco M; Fabris L
    Dig Dis; 2015; 33 Suppl 2(Suppl 2):140-8. PubMed ID: 26641079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with major radiological progression of primary sclerosing cholangitis in patients with inflammatory bowel disease.
    Azzam N; AlRuthia Y; Alharbi O; Aljebreen A; Almadi M; Loftus EV
    Hepatol Int; 2020 Dec; 14(6):1114-1124. PubMed ID: 33369708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of MRCP in surveillance of primary sclerosing cholangitis associated hepatobiliary malignancy: 15 year experience at a single institution in Ontario, Canada.
    Nair AV; Macdonald DB; Kelly EM; Satheesh S; Venugopalan P; Soman DK
    Clin Imaging; 2022 Jan; 81():47-53. PubMed ID: 34598005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.